课题基金 / 基金详情

Improving Treatment Outcomes and Value for Recurrent Clostridium difficile Infection through a Platform Adaptive Trial

Improving Treatment Outcomes and Value for Recurrent Clostridium difficile Infection through a Platform Adaptive Trial
通过平台适应性试验改善复发性艰难梭菌感染的治疗结果和价值
批准号：
378818
负责人：
Lee Christine H
金额：
$7.29万
依托单位：
Vancouver Island Health Authority
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-02-01 至 2019-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=378818&lang=en
关键词：
Disease Control Gastroenterology Infectious Diseases Patient-Oriented Research Platform Adaptive Trial Public Health

项目摘要

项目成果

Lee Christine H的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The impact of recurrent C Diff (rCD) infection is debilitating, and disrupts the lives of patients and their families. Current standard treatments for rCD are only 40% effective. We propose to compare five different treatments for rCD, including freeze-dr
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving Treatment Outcomes and Value for Recurrent Clostridium difficile Infection through a Platform Adaptive Trial
  • 批准号：
    378767
  • 项目类别：
    Miscellaneous Programs
  • 资助金额：
    $0.18万
  • 财政年份：
    2017
  • 负责人：
    Lee Christine H
  • 依托单位：
    Vancouver Island Health Authority
海外基金